NHS jab targeting dozens of cancers could slash treatment time by 90%

1 sources1 storiesFirst seen 5/3/2026Score26Mixed Progress

Single Source

Bigness

Coverage

Recency

Engagement

Velocity

Confidence

Clipability

Polarization

Claims

Contradictions

Breakthrough

Sentiment Mix

Positive100%

Neutral0%

Negative0%

Geography

North America

Expert Signals

GB News - News

source • 1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

NHS jab targeting dozens of cancers could slash treatment time by 90%.

Supported by 1 story

Tens of thousands of patients could benefit from a one-minute jab being rolled out on the NHS for more than a dozen cancers.The immunotherapy injection works by telling the body's immune system to recognise and kill cancer cells and is powerful against several types of the disease, including lung, breast, head and neck, and cervical cancer.Until now, patients have had to spend long periods on a drip to get the drug pembrolizumab (Keytruda) into their system.

Supported by 1 story

A new injectable form means the time needed for treatment can be slashed by up to 90 per cent.One of the first patients to receive the new injection on the NHS was 89-year-old Shirley Xerxes from St Albans in Hertfordshire, who has bowel cancer.

Supported by 1 story

TRENDING Stories Videos Your Say She was treated at the Mount Vernon Cancer Centre, part of East and North Hertfordshire Teaching NHS Trust.She told PA: "Having the injection has been great and the nurse was so good, so kind."I just had it in my tummy.

Supported by 1 story